- Brown & Brown reported third quarter 2026 results, with revenue of US$1.725b, net income of US$240m and mixed basic versus diluted EPS trends from continuing operations.
- The nine-month figures, including US$5.302b in revenue and US$954m in net income, highlight how Accession integration and organic expansion are shaping Brown & Brown's earnings mix and scale.
- We now look at how Brown & Brown's investment narrative is affected by the latest revenue and earnings progress.
Scan beyond Brown & Brown's latest earnings and line up other potential value opportunities with our hand picked list of 38 high quality undervalued stocks.
Brown & Brown Investment Narrative Recap
For Brown & Brown, the core belief as a shareholder is that a steady insurance brokerage model, plus Accession and AI tools, can keep earnings resilient even when individual segments face pressure. The latest quarter fits that picture. Revenue and net income were higher than a year ago, which supports the idea that integration and organic trends are still moving in the right direction.
The near term swing factor is execution on Accession synergies and producer retention. Recent results suggest Accession is contributing to scale, while basic EPS from continuing operations improved. Diluted EPS was flat to slightly softer, so margin mix and share based compensation remain things to watch, but nothing in this report appears to materially shift the main risk drivers.
The most relevant disclosure is Brown & Brown’s third quarter and nine month 2026 earnings update. You saw revenue of US$1.725b in the quarter and US$5.302b year to date, with net income of US$240m and US$954m respectively. Basic EPS from continuing operations moved higher, while diluted EPS in both periods stayed roughly flat compared with last year.
For catalysts, that combination matters. It points to a business that is adding scale through Accession and organic expansion while still working through producer turnover and CAT property pressure mentioned earlier. If the firm keeps integrating Accession, rolls out AI tools and holds underwriting quality, that earnings profile underpins management’s focus areas, even if top line or margins fluctuate quarter to quarter.
Brown & Brown's narrative projects US$7.9b revenue and US$1.3b earnings by 2029. That profile assumes 5.7% yearly revenue growth and an earnings increase of about US$100m from US$1.2b today.
Uncover why Brown & Brown's fair value indicates a 4% potential upside to its current price, which could close faster than many investors expect.
Exploring Other Perspectives
Three fair value estimates from the Simply Wall St Community cluster between US$74.75 and about US$96.74 per share, which shows how far opinions on Brown & Brown can stretch. Those views sit beside real execution questions around tariffs, CAT property pricing and producer churn, so you are wise to compare several viewpoints before leaning on any single narrative.
Explore 2 other Brown & Brown fair value estimates, including one that suggests it could be worth just $74.75.
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Brown & Brown research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- See our latest analysis for Brown & Brown. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Brown & Brown's overall financial health at a glance.
Looking For More Investment Ideas Beyond Brown & Brown?
If Brown & Brown's story has sharpened your thinking but you want a wider watchlist, it helps to line up a few very different filters and see which companies keep showing up.
- For investors who want potential upside without ignoring quality, start with a focused group of 19 high quality undiscovered gems that pair strong fundamentals with limited market attention.
- If defense matters more than excitement right now, narrow your search to a 31 resilient stocks with low risk scores that screens for businesses with more resilient profiles.
- For those who care about balance sheet strength as much as the income statement, zero in on a list of solid balance sheet and fundamentals (25 results) and see which companies pass tougher financial health filters.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com